517 related articles for article (PubMed ID: 24811054)
41. Irritable bowel syndrome in quiescent inflammatory bowel disease: a review.
Burgell RE; Asthana AK; Gibson PR
Minerva Gastroenterol Dietol; 2015 Dec; 61(4):201-13. PubMed ID: 26426460
[TBL] [Abstract][Full Text] [Related]
42. Inflammatory bowel disease, irritable bowel syndrome, or what?: A challenge to the functional-organic dichotomy.
Long MD; Drossman DA
Am J Gastroenterol; 2010 Aug; 105(8):1796-8. PubMed ID: 20686466
[TBL] [Abstract][Full Text] [Related]
43. Cytokines and irritable bowel syndrome: where do we stand?
Bashashati M; Rezaei N; Andrews CN; Chen CQ; Daryani NE; Sharkey KA; Storr MA
Cytokine; 2012 Feb; 57(2):201-9. PubMed ID: 22178716
[TBL] [Abstract][Full Text] [Related]
44. Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology.
Dinan TG; Cryan JF
Psychoneuroendocrinology; 2012 Sep; 37(9):1369-78. PubMed ID: 22483040
[TBL] [Abstract][Full Text] [Related]
45. The overlap between IBS and IBD: what is it and what does it mean?
Stanisic V; Quigley EM
Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):139-45. PubMed ID: 24417262
[TBL] [Abstract][Full Text] [Related]
46. Association of TNFSF15 polymorphism with irritable bowel syndrome.
Zucchelli M; Camilleri M; Andreasson AN; Bresso F; Dlugosz A; Halfvarson J; Törkvist L; Schmidt PT; Karling P; Ohlsson B; Duerr RH; Simren M; Lindberg G; Agreus L; Carlson P; Zinsmeister AR; D'Amato M
Gut; 2011 Dec; 60(12):1671-1677. PubMed ID: 21636646
[TBL] [Abstract][Full Text] [Related]
47. Gene, environment, and brain-gut interactions in irritable bowel syndrome.
Fukudo S; Kanazawa M
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():110-5. PubMed ID: 21443722
[TBL] [Abstract][Full Text] [Related]
48. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.
Ohman L; Simrén M
Nat Rev Gastroenterol Hepatol; 2010 Mar; 7(3):163-73. PubMed ID: 20101257
[TBL] [Abstract][Full Text] [Related]
49. Bacterial proteases in IBD and IBS.
Steck N; Mueller K; Schemann M; Haller D
Gut; 2012 Nov; 61(11):1610-8. PubMed ID: 21900548
[TBL] [Abstract][Full Text] [Related]
50. A Comparative Study of Quality of Life in Persons With Irritable Bowel Syndrome and Inflammatory Bowel Disease.
Blagden S; Kingstone T; Soundy A; Lee R; Singh S; Roberts L
Gastroenterol Nurs; 2015; 38(4):268-78. PubMed ID: 26226021
[TBL] [Abstract][Full Text] [Related]
51. Infection, inflammation, and the irritable bowel syndrome.
Spiller R; Garsed K
Dig Liver Dis; 2009 Dec; 41(12):844-9. PubMed ID: 19716778
[TBL] [Abstract][Full Text] [Related]
52. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
[TBL] [Abstract][Full Text] [Related]
53. Post-Infectious Irritable Bowel Syndrome.
Lee YY; Annamalai C; Rao SSC
Curr Gastroenterol Rep; 2017 Sep; 19(11):56. PubMed ID: 28948467
[TBL] [Abstract][Full Text] [Related]
54. (Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review.
Hagan M; Hayee BH; Rodriguez-Mateos A
Molecules; 2021 Mar; 26(7):. PubMed ID: 33805938
[TBL] [Abstract][Full Text] [Related]
55. Inflammatory bowel diseases: a dysfunction of brain-gut interactions?
Bonaz B
Minerva Gastroenterol Dietol; 2013 Sep; 59(3):241-59. PubMed ID: 23867945
[TBL] [Abstract][Full Text] [Related]
56. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.
Öhman L; Törnblom H; Simrén M
Nat Rev Gastroenterol Hepatol; 2015 Jan; 12(1):36-49. PubMed ID: 25446728
[TBL] [Abstract][Full Text] [Related]
57. Concept of Crohn's disease being conditioned by four main components, and irritable bowel syndrome being an incomplete Crohn's disease.
Olbe L
Scand J Gastroenterol; 2008; 43(2):234-41. PubMed ID: 17918000
[TBL] [Abstract][Full Text] [Related]
58. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
Putignani L; Del Chierico F; Vernocchi P; Cicala M; Cucchiara S; Dallapiccola B;
Inflamm Bowel Dis; 2016 Feb; 22(2):487-504. PubMed ID: 26588090
[TBL] [Abstract][Full Text] [Related]
59. Irritable bowel syndrome in inflammatory bowel disease. Synergy in alterations of the gut-brain axis?
Pérez de Arce E; Quera R; Beltrán CJ; Madrid AM; Nos P
Gastroenterol Hepatol; 2022 Jan; 45(1):66-76. PubMed ID: 34023477
[TBL] [Abstract][Full Text] [Related]
60. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
